The angiotensin II type 2 receptor in the brain
Author(s) -
Masatsugu Horiuchi,
Masaki Mogi,
Masaru Iwai
Publication year - 2009
Publication title -
journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320309347793
Subject(s) - angiotensin ii , receptor , renin–angiotensin system , angiotensin receptor , medicine , angiotensin ii receptor type 1 , neurogenesis , stroke (engine) , endocrinology , neuroscience , pharmacology , biology , blood pressure , mechanical engineering , engineering
Recent clinical studies indicate that blockade of the renin-angiotensin system is important to prevent stroke, and accumulating results of basic research also indicate the possible involvement of the central renin-angiotensin system in ischaemic brain damage and cognition. When the angiotensin II type 1 receptor is blocked by an angiotensin type 1 receptor blocker, unbound angiotensin II acts preferentially on the angiotensin II type 2 (AT 2 ) receptor. These results suggest the pathophysiological importance of the AT 2 receptor in the clinical use of angiotensin type 1 receptor blockers, which are widely used in patients with hypertension with the expectation of a decrease in the onset of cardiovascular and cerebrovascular disease. We review here the possible roles of AT 2 receptor activation in the brain, focusing on ischaemic stroke, cognitive function and neurogenesis, and potential effects of specific AT 2 receptor agonists.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom